ESAB vs Symbotic
ESAB and SYM side by side, both in general industrial machinery and equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ESAB and SYM compare
Symbotic is the larger company, worth 4.2 times as much as ESAB ($22.4B against $5.3B).
On earnings, ESAB is cheaper: it trades at 29.8× trailing earnings, against 742× for Symbotic.
Symbotic grew revenue faster over the last twelve months (20.6% versus 11.0% for ESAB).
ESAB keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with 0.31% at Symbotic.
ESAB pays a dividend yielding 0.51%; Symbotic does not pay one.
Symbotic scores higher on the StockData Score (10 against 7 for ESAB), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ESAB | SYM |
|---|---|---|
| Size and price | ||
| Market cap | $5.3B | $22.4B |
| Share price | $85.82 | $37.11 |
| Change, 1 year | −25.4% | −47.5% |
| Change, 5 years | – | 273% |
| Beta (5Y) | 1.14 | 1.04 |
| Employees | 10K | 2,000 |
| StockData Score | ||
| Total score | 7 | 10 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 6 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 29.8× (better) | 742× |
| P/S | 1.7× (better) | 8.5× |
| P/B | 2.1× (better) | 31.7× |
| EV/EBITDA | 16.1× (better) | 546× |
| P/FCF | 29.5× | – |
| FCF yield | 3.4% | – |
| Fair value | $78.32 | $6.09 |
| Margin of safety | −9.6% (better) | −509% |
| Growth | ||
| Revenue growth (TTM) | 11.0% | 20.6% (better) |
| Revenue growth, 5Y average | 7.8% | 89.4% (better) |
| Net income growth (TTM) | −35.5% | – |
| EPS growth (TTM) | −32.6% | – |
| EPS growth, 5Y average | 7.0% | – |
| Profitability | ||
| Gross margin | 37.6% (better) | 21.3% |
| Operating margin | 11.2% (better) | −0.01% |
| Net margin | 5.1% (better) | 0.31% |
| FCF margin | 5.8% | – |
| Return on equity | 6.7% (better) | 1.8% |
| Return on invested capital | 6.9% | – |
| Financial health | ||
| Debt / equity | 0.91 (better) | 0.00 |
| Net debt / EBITDA | 4.59 | – |
| Current ratio | 1.92 (better) | 1.33 |
| Altman Z-score | 1.80 | 6.10 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.51% | – |
| Payout ratio | 16.5% | – |
| Years of dividend growth | 3 | – |
| Buyback yield | – | −1.9% |
| Shareholder yield | 0.51% (better) | −1.9% |
| Ownership | ||
| Held by institutions | 105% | 19.2% |
| Held by insiders | 7.7% | 85.8% |
| Insider net buying, 12 months | −$8.8M (better) | −$962M |
| Short interest, % of float | 8.8% | 20.4% |
Go deeper
- ESAB stock overview
- ESAB income statement
- ESAB valuation and score
- SYM stock overview
- SYM income statement
- SYM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.